Through
4/26
A round-up of Penn mentions in local, national, and international media.
Penn In the News
Drew Weissman of the Perelman School of Medicine, whose key discoveries about mRNA contributed to Moderna and BioNTech, says that mRNA is designed to rapidly adapt to new strains and variants of virus.
Penn In the News
Mark Pauly of the Wharton School asserts that it is wasteful to help people who could probably afford health insurance.
Penn In the News
Stefano Puntoni of the Wharton School one reason people might not respond to targeted medical recommendations is when they feel like the recommendation has fundamentally misunderstood them as people.
Penn In the News
Kermit Roosevelt of Penn Carey Law comments that any right that is not textually enumerated is under threat from the current Supreme Court.
Penn In the News
Steve Viscelli of the School of Arts & Sciences comments on the freight sector moving more rapidly toward autonomous transport than the passenger-car business.
Penn In the News
Diane Spatz of the School of Nursing comments on how parents who want to breastfeed need a strong support network.
Penn In the News
Daniel Taylor of the Wharton School discusses the prospect of a regulatory lawsuit against Elon Musk.
Penn In the News
E. John Wherry of the Perelman School of Medicine relays data from his lab showing that, after the initial series of vaccines, T cells remain in the body for at least nine to 12 months.
Penn In the News
Graciela Gonzalez-Hernandez and Ashish Thakrar of the Perelman School of Medicine discuss some of the benefits of using social-media data in studies related to patient care and outcomes.
Penn In the News
Admissions Dean Whitney Soule said drawing attention to the acceptance rate of Ivy League schools like Penn does more harm than good, distressing applicants and their parents. “We’re focusing not on how hard we are to get into but on who these young people are that we chose,” she said.